SE468831B - Monoklonala antikroppar som aer korsreaktiva och korsprotektiva mot p aeruginosa-sero-typer - Google Patents

Monoklonala antikroppar som aer korsreaktiva och korsprotektiva mot p aeruginosa-sero-typer

Info

Publication number
SE468831B
SE468831B SE8605295A SE8605295A SE468831B SE 468831 B SE468831 B SE 468831B SE 8605295 A SE8605295 A SE 8605295A SE 8605295 A SE8605295 A SE 8605295A SE 468831 B SE468831 B SE 468831B
Authority
SE
Sweden
Prior art keywords
antibody
iats
serotypes
fisher
iats serotypes
Prior art date
Application number
SE8605295A
Other languages
English (en)
Swedish (sv)
Other versions
SE8605295D0 (sv
SE8605295L (sv
Inventor
A W Siadak
M J Rosok
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of SE8605295D0 publication Critical patent/SE8605295D0/xx
Publication of SE8605295L publication Critical patent/SE8605295L/xx
Publication of SE468831B publication Critical patent/SE468831B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1214—Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE8605295A 1985-12-10 1986-12-10 Monoklonala antikroppar som aer korsreaktiva och korsprotektiva mot p aeruginosa-sero-typer SE468831B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80739485A 1985-12-10 1985-12-10
US93117986A 1986-11-24 1986-11-24

Publications (3)

Publication Number Publication Date
SE8605295D0 SE8605295D0 (sv) 1986-12-10
SE8605295L SE8605295L (sv) 1987-06-11
SE468831B true SE468831B (sv) 1993-03-29

Family

ID=27123006

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8605295A SE468831B (sv) 1985-12-10 1986-12-10 Monoklonala antikroppar som aer korsreaktiva och korsprotektiva mot p aeruginosa-sero-typer

Country Status (21)

Country Link
US (4) US5378812A (de)
JP (1) JPH07116237B2 (de)
KR (1) KR910008361B1 (de)
CN (1) CN86108380A (de)
AT (1) AT400441B (de)
BE (1) BE905890A (de)
CH (1) CH677362A5 (de)
DE (1) DE3642095C2 (de)
DK (1) DK594586A (de)
FI (1) FI86377C (de)
FR (1) FR2593826B1 (de)
GB (1) GB2185266B (de)
HU (1) HUT41836A (de)
IE (1) IE59741B1 (de)
IT (1) IT1199735B (de)
LU (1) LU86711A1 (de)
NL (1) NL8603132A (de)
NO (1) NO178718C (de)
NZ (1) NZ218499A (de)
PT (1) PT83894B (de)
SE (1) SE468831B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
AU615162B2 (en) * 1986-07-03 1991-09-26 Genetic Systems Corporation Monoclonal antibodies to pseudomonas aeruginosa flagella
EP0256713A3 (de) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutische, menschliche Antipseudomonas-Aeruginosa-Antikörper
WO1990011350A1 (en) * 1989-03-20 1990-10-04 Mitsui Toatsu Chemicals, Inc. Human monoclonal antibody reactive with pseudomonas aeruginosa, cell which produces the antibody, method of production, and pharmaceutical preparation
WO1988004669A1 (fr) * 1986-12-15 1988-06-30 Mitsui Toatsu Chemicals, Inc. Anticorps monoclonal humain et medicament pour la prophylaxie et le traitement de maladies infectieuses comprenant ledit anticorps en tant qu'ingredient efficace
US5521085A (en) * 1986-12-15 1996-05-28 Mitsui Toatsu Chemicals, Inc. Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes
JPH01197500A (ja) * 1988-01-29 1989-08-09 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
GB2218703B (en) * 1988-05-10 1992-10-28 Sumitomo Chemical Co Human monoclonal antibody to p.aeruginosa: its production and use
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
EP0382031A3 (de) * 1989-02-10 1991-06-26 Miles Inc. Monoklonal-Antikörper in einer Zusammensetzung von Globulin aus Immunserum
US4994269A (en) * 1989-03-17 1991-02-19 Miles Inc. Topical use of antibodies for prevention or treatment of pseudomonas infections
JPH02283294A (ja) * 1989-04-24 1990-11-20 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
AU5675790A (en) * 1989-05-09 1990-11-29 Cetus Corporation Human monoclonal antibodies to sero-specific determinants of gram-negative bacteria
US5858728A (en) * 1991-03-13 1999-01-12 Common Services Agency Monoclonal antibody against LPS core
US20030096315A1 (en) 2000-05-03 2003-05-22 Sanders Mitchell C. Device for detecting bacterial contamination and method of use
US9017963B2 (en) * 2002-01-31 2015-04-28 Woundchek Laboratories (Us), Inc. Method for detecting microorganisms
US20060292562A1 (en) * 2002-05-29 2006-12-28 Pollard Harvey B Methods of identifying genomic and proteomic biomarkers for cystic fibrosis, arrays comprising the biomarkers and methods of using the arrays
ATE544354T1 (de) 2002-11-26 2012-02-15 Univ Chicago Vermeidung und behandlung von mikrobenübertragenen epithelerkrankungen
CA2514938A1 (en) * 2003-01-31 2004-10-14 Ethicon, Inc. Method for detecting escherichia coli
US8609358B2 (en) * 2003-11-03 2013-12-17 Systagenix Wound Management (Us), Inc. Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
EP1690875A1 (de) * 2005-02-14 2006-08-16 Kenta Biotech AG Menschlicher Monoklonaler Antikörper, welcher spezifisch für lipopolysaccharide (LPS) von Pseudomonas aeruginosa IATS O11 ist
EP2012669B1 (de) * 2006-05-01 2013-03-13 Bioness Neuromodulation Ltd Verbesserte funktionale elektrische stimulationssysteme
US20100272736A1 (en) * 2009-02-04 2010-10-28 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
JP2013521758A (ja) * 2010-02-18 2013-06-13 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 緑膿菌の血清型ａ型リポ多糖に対する抗体
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en) 2020-07-22 2026-01-27 David Gordon Bermudes Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH652145A5 (de) * 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
JPS59137497A (ja) * 1983-01-20 1984-08-07 ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア 抗原特異的免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
JPS58216125A (ja) * 1982-06-09 1983-12-15 Asahi Chem Ind Co Ltd ヒト抗体の産生方法
JPS5929622A (ja) * 1982-08-10 1984-02-16 Meiji Seika Kaisha Ltd モノクロ−ナル抗体、その製造法およびその用途
DE3484773D1 (de) * 1983-05-06 1991-08-08 Velos Group Mit endotoxinkern reaktionsfaehige monoklonale antikoerper.
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US4683196A (en) * 1983-12-12 1987-07-28 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
EP0168422A1 (de) * 1983-12-12 1986-01-22 Meru, Inc. Verfahren und materialien zum nachweis von mikroorganismen erzeugenden liposacchariden
JP2565303B2 (ja) * 1984-05-25 1996-12-18 三井東圧化学株式会社 緑膿菌感染症の予防治療剤
JPS60248625A (ja) * 1984-05-25 1985-12-09 Mitsui Toatsu Chem Inc 抗緑膿菌モノクロ−ナル抗体、その製法ならびに用途
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
EP0233289B1 (de) * 1984-12-26 1993-03-10 Teijin Limited Humaner monoklonaler antikörper gegen pseudomonas aeruginosagegen pseudomonas aeruginosa produzierende hybridomen
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
JPS6229175A (ja) * 1985-07-29 1987-02-07 Nippon Telegr & Teleph Corp <Ntt> 電界効果型トランジスタの製造方法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
EP0211352B1 (de) * 1985-08-01 1994-03-16 Miles Inc. Schützende Antikörper gegen serotypische Determinanten von flagellären Antigenen
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
US4970070A (en) * 1986-02-07 1990-11-13 Genetic Systems Corporation Protective monoclonal antibody compositions for infections due to group B streptococcus
AU615162B2 (en) * 1986-07-03 1991-09-26 Genetic Systems Corporation Monoclonal antibodies to pseudomonas aeruginosa flagella
EP0256713A3 (de) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutische, menschliche Antipseudomonas-Aeruginosa-Antikörper

Also Published As

Publication number Publication date
SE8605295D0 (sv) 1986-12-10
BE905890A (fr) 1987-06-10
NO864971D0 (no) 1986-12-10
SE8605295L (sv) 1987-06-11
FR2593826B1 (fr) 1990-11-16
NO178718C (no) 1996-05-22
FI86377B (fi) 1992-05-15
US5662905A (en) 1997-09-02
LU86711A1 (fr) 1988-07-14
JPH07116237B2 (ja) 1995-12-13
NO178718B (no) 1996-02-12
US5628996A (en) 1997-05-13
IT8622630A0 (it) 1986-12-10
JPS62187417A (ja) 1987-08-15
DK594586D0 (da) 1986-12-10
AT400441B (de) 1995-12-27
NZ218499A (en) 1990-04-26
DE3642095C2 (de) 1998-10-01
GB2185266A (en) 1987-07-15
KR910008361B1 (ko) 1991-10-12
CN86108380A (zh) 1987-10-28
KR870005648A (ko) 1987-07-06
HUT41836A (en) 1987-05-28
PT83894B (pt) 1989-07-31
GB2185266B (en) 1990-09-05
DE3642095A1 (de) 1987-07-02
IE59741B1 (en) 1994-03-23
CH677362A5 (de) 1991-05-15
NO864971L (no) 1987-06-11
PT83894A (en) 1987-01-01
FR2593826A1 (fr) 1987-08-07
ATA328286A (de) 1995-05-15
FI865027A7 (fi) 1987-06-11
IT1199735B (it) 1988-12-30
US5627067A (en) 1997-05-06
DK594586A (da) 1987-06-11
NL8603132A (nl) 1987-07-01
FI865027A0 (fi) 1986-12-10
IE863230L (en) 1987-06-10
FI86377C (fi) 1992-08-25
US5378812A (en) 1995-01-03
GB8629540D0 (en) 1987-01-21

Similar Documents

Publication Publication Date Title
FI86377B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva humana monoklonala antikroppar eller deras bindande fragment.
US4689299A (en) Human monoclonal antibodies against bacterial toxins
US4834975A (en) Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
EP0105804B1 (de) Menschliche monoklonale Antikörper gegen bakterielle Toxine
JPH0776240B2 (ja) エンドトキシンコア−と反応性のモノクロ−ナル抗体
FI94489B (fi) Menetelmä ristisuojaavien ihmisen monoklonaalisten vasta-aineiden valmistamiseksi ja vasta-ainetta tuottava solulinja
Morrison-Plummer et al. Biological effects of anti-lipid and anti-protein monoclonal antibodies on Mycoplasma pneumoniae
US4834976A (en) Monoclonal antibodies to pseudomonas aeruginosa flagella
EP0193576A1 (de) Monoklonale antikörper und deren verwendung
Stoll et al. Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide
WO2008004536A1 (fr) Procédé de détection de toxine
AU615162B2 (en) Monoclonal antibodies to pseudomonas aeruginosa flagella
Chandad et al. Antigenic, structural, and functional relationships between fimbriae and the hemagglutinating adhesin HA-Ag2 of Porphyromonas gingivalis
Lang et al. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization
Verschoor et al. Monoclonal antibody characterization of two field strains of Haemophilus paragallinarum isolated from vaccinated layer hens
Siadak et al. Cell-driven viral transformation
FI102217B (fi) Menetelmä Pseudomonas aeruginosa-serotyyppien toteamiseksi näytteestä in vitro monoklonaalisten vasta-aineiden avulla, menetelmässä käytettä viä monoklonaalisia vasta-aineita sekä menetelmässä käyttökelpoinen te stipakkaus
EP0326148A1 (de) Menschlicher monoklonaler Antikörper spezifisch für Pseudomonas aeruginosa und Hybridzellinien
Dénes et al. Recognition of multiple Mycoplasma bovis antigens by monoclonal antibodies
JPH0355106B2 (de)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8605295-8

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8605295-8

Format of ref document f/p: F